For Liberation Treatment for MS patients in
India please click
http://www.mediescapes.com/Neurology_Consultant.html
At the present moment following diseases / conditions are dealt using
stem cells
by Mediescapes India specific to our Indian collaborations*:
1. Cerebral Palsy :
Cerebral palsy refers to a neurological disorders that appear in
infancy or early childhood and permanently affect body movement and
muscle coordination but don’t worsen over time. It is caused
by abnormalities in parts of the brain that control muscle
movements. The majority of children with cerebral palsy are
born with it, although it may not be detected until months or years
later. The early signs of cerebral palsy usually appear before a
child reaches 3 years of age. Cerebral palsy can’t be cured, but
treatment will often improve a child's capabilities.
StemOne is proud to announce that we have completed almost 30
patients for cellular work of stem cell therapy for Cerebral Palsy.
Out of which almost 80 % have shown very encouraging results just
after their first shot and the rest have shown some improvements
after their 2nd shot.
2. Cerebral Palsy with Mental
Retardation : Mental retardation is a generalized
disorder, characterized by sub-average cognitive functioning and
deficits in two or more adaptive behaviors with onset before the age
of 18. Once focused almost entirely on cognition, the definition now
includes both a component relating to mental functioning and one
relating to the individual's functional skills in their environment.
3. Trauma : A trauma
patient is someone who has suffered serious and life-threatening
physical injury with the potential for secondary complications such
as shock, respiratory failure and death. Trauma is defined as any
body wound or shock produced by sudden physical injury, as from
accident, injury, or impact. Trauma patients may require specialized
care, including surgery and blood transfusion, within the so-called
golden hour of emergency medicine, the first sixty minutes after
trauma occurs. This is not a strict deadline, but recognizes that
many deaths which could have been prevented by appropriate care
occur a relatively short time after injury.
4. Bedsore :
Bedsores, more properly known as pressure ulcers or decubitus ulcers,
are lesions caused by many factors such as: unrelieved pressure;
friction; humidity; shearing forces; temperature; age; continence
and medication; to any part of the body, especially portions over
bony or cartilaginous areas such as sacrum, elbows, knees, ankles
etc. Although easily prevented and completely treatable if found
early, bedsores are often fatal – even under the auspices of medical
care – and are one of the leading iatrogenic causes of death
reported in developed countries, second only to adverse drug
reactions.
5. Stroke ; A stroke
is the rapidly developing loss of brain function(s) due to
disturbance in the blood supply to the brain. This can be due to
ischemia (lack of blood supply) caused by thrombosis or embolism or
due to a hemorrhage. As a result, the affected area of the brain is
unable to function, leading to inability to move one or more limbs
on one side of the body, inability to understand or formulate speech
or inability to see one side of the visual field
6. Spinal Cord Injury :
Spinal cord injuries cause myelopathy or damage to white
matter or myelinated fiber tracts that carry signals to and from the
brain. It also damages gray matter in the central part of the spine,
causing segmental losses of interneurons and motorneurons.
A Spinal Cord Injury (SCI) is typically defined as damage or trauma
to the spinal cord that in turn results in a loss or impaired
function resulting in reduced mobility or feeling.
Typical common causes of damage to the spinal cord, are trauma
(car/motorcycle accident, gunshot, falls, sports injuries, etc), or
disease (Transverse Myelitis, Polio, Spina Bifida, Friedreich's
Ataxia, etc.). The resulting damage to the spinal cord is known as a
lesion, and the paralysis is known as Quadriplegia or Quadraplegia /
Tetraplegia if the injury is in the Cervical (neck) region, or as
Paraplegia if the injury is in the Thoracic, Lumbar or Sacral
region.
7. Quadriplegia :
Quadriplegia, also known as tetraplegia, is a symptom in which a human
experiences paralysis affecting all four limbs, although not
necessarily total paralysis or loss of function.
It is caused by damage to the brain or the spinal cord at a high
level - in particular spinal cord injuries secondary to an injury to
the cervical spine. The injury, known as a lesion, causes victims to
lose partial or total mobility of all four limbs, meaning the arms
and the legs.
Typical causes of this damage are trauma (such as car crash,
gunshot wound, fall, or sports injury) or disease (such as
transverse myelitis, polio, or spina bifida).
8. Quadriparesis :
Weakness of all four limbs, both arms and both legs, as for example
from muscular dystrophy
9. Ischemic Encephalopathy :
Encephalopathy alters brain function and/or structure. It may
be caused by an infectious agent (bacteria, virus, or prion),
metabolic or mitochondrial dysfunction, brain tumor or increased
intracranial pressure, exposure to toxins (including solvents,
excess animal protein, drugs, alcohol, paints, industrial chemicals,
and certain metals), radiation, trauma, poor nutrition, or lack of
oxygen or blood flow to the brain.
The hallmark of encephalopathy is an altered mental state.
Depending on the type and severity of encephalopathy, common
neurological symptoms are loss of cognitive function, subtle
personality changes, inability to concentrate, lethargy, and
depressed consciousness.
10. Progressive Supranuclear Palsy :
It is a rare degenerative disease involving the
gradual deterioration and death of selected areas of the brain
The initial symptom in two-thirds of cases is loss of balance and
falls. Other common early symptoms are changes in personality,
general slowing of movement, and visual symptoms.
Later symptoms and signs are dementia (typically including loss of
inhibition and ability to organize information), slurring of speech,
difficulty swallowing, and difficulty moving the eyes, particularly
in the vertical direction. The latter accounts for some of the falls
experienced by these patients as they are unable to look up or down.
Some of the other signs are poor eyelid function, contracture of
the facial muscles, a backward tilt of the head with stiffening of
the neck muscles, sleep disruption, urinary incontinence and
constipation
11. Autism : Autism
is a brain development disorder characterized by impaired social
interaction and communication, and by restricted and repetitive
behavior. These signs all begin before a child is three years old.
The autism spectrum disorders (ASD) also include the related
conditions Asperger syndrome and PDD-NOS, which have fewer signs and
symptoms
12. Critical limb ischemia / ischemic ulcer
of the leg, foot especially in
diabetic patients untreatable with conventional treatments such as
bypass
surgery
13. Ischemic heart diseases and
cardiomyopathy untreatable with
conventional treatments such as angioplasty, stents or bypass
surgery.
Ischemic or ischemic heart disease (IHD), or myocardial ischemia,
is a disease characterized by reduced blood supply to the heart
muscle, usually due to coronary artery disease (atherosclerosis of
the coronary arteries). Its risk increases with age, smoking,
hypercholesterolemia (high cholesterol levels), diabetes,
hypertension (high blood pressure) and is more common in men and
those who have close relatives with ischemic heart disease.
Symptoms of stable ischemic heart disease include angina
(characteristic chest pain on exertion) and decreased exercise
tolerance.
14. Cirrhosis of Liver
15. Oral Submucal Fibrosis
* In India as per the ICMR guidelines the stem cell application is
done as an experimental therapy and the guidelines are available at:
http://www.icmr.nic.in/stem_cell/stem_cell_guidelines.pdf
For diseases which are not mentioned above you may send an email with
complete details of the patient. A latest discharge summary would be
ideal. This would be put forth to our team of physicians and we
shall revert **.
1. Alzheimer's disease : Alzheimer's disease
(AD), also called Alzheimer disease, Senile Dementia of the
Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form
of dementia. In the early stages, the most commonly recognised
symptom is memory loss, such as difficulty in remembering recently
learned facts. When a doctor or physician has been notified, and AD
is suspected, the diagnosis is usually confirmed with behavioural
assessments and cognitive tests, often followed by a brain scan if
available. As the disease advances, symptoms include confusion,
irritability and aggression, mood swings, language breakdown,
long-term memory loss, and the general withdrawal of the sufferer as
their senses decline. Gradually, bodily functions are lost,
ultimately leading to death. Individual prognosis is difficult to
assess, as the duration of the disease varies. AD develops for an
indeterminate period of time before becoming fully apparent, and it
can progress undiagnosed for years.
2. Parkinson's disease:
Parkinson's disease is a degenerative disease of the brain (central
nervous system) that often impairs motor skills, speech, and other
functions. Parkinson's disease belongs to a group of conditions
called movement disorders. It is characterized by muscle rigidity,
tremor, a slowing of physical movement (bradykinesia) and, in
extreme cases, a loss of physical movement (akinesia). The primary
symptoms are the results of decreased stimulation of the motor
cortex by the basal ganglia, normally caused by the insufficient
formation and action of dopamine, which is produced in the
dopaminergic neurons of the brain. Secondary symptoms may include
high level cognitive dysfunction and subtle language problems. PD is
both chronic and progressive.
3. Ischemic
stroke
4. Sensory Neural hearing loss
5. Motor Neuron Disease (ALS)
** We also reserve the right to refer few selected cases to our
partners in China for their further stem cell induction therapies.
------------------------------------------------------------------------------------------------
Current status of Stem Cell Treatment in India - For Heart Disease
Adult stem cell treatment has been found to be useful for Advanced
Coronary artery disease and heart Muscle damage after Myocardial
Infarction (heart attack). The stem cells are Injected either into
the coronary arteries via a special catheter or directly into the
Heart muscle. In very high risk cases it can be injected in a
Peripheral vein. Many studies have shown 20-40 % improvement in the
Pumping capacity (Ejection fraction) and circulation status of the
Heart using Stem cell therapy. The procedure is entirely painless.
Recent Clinical trials - like The "BOOST TRIAL" and "REPAIR - MI" have
confirmed the value of Adult Stem cells in the treatment of Heart
patients having Low Ejection fraction or advanced Coronary artery
disease.
------------------------------------------------------------------------------------------------
Current status of Stem Cell Treatment in India - For Spinal Cord
Injuries
Stem cells have found use in Patients with Muscular or Bladder
paralysis after Spinal Cord Injury. In patients with paraplegia.
This therapy is of maximum use in patients 1-2 years after Spinal
cord injury. It could also be potentially of use for patients with
other neurological diseases of the spinal cord. In the future the
therapy may be useful for patients with Brain Damage also. Stem cell
Injected directly into the Spinal fluid or around the spinal cord,
at the site of injury has been found to improve nerve function. The
Injection procedure is done under local anesthesia and is painless.
------------------------------------------------------------------------------------------------
Current status of Stem Cell Treatment in India - For Liver Failure
Stem cells have shown to be of value in patients with reduced
liver function and cirrhosis with Liver fibrosis. Direct injection
into the hepatic artery has also shown good clinical improvement in
many patients.
This is a major medical breakthrough as Acute Liver failure has no
definitive therapy and patients will not be able to survive the long
wait for a Liver transplantation
------------------------------------------------------------------------------------------------
Current status of Stem Cell Treatment in India - For CANCERr
Natural Killer cells (NK cells) which can be purified from the
peripheral blood is found to be beneficial even in late cases of
cancers like - Melanoma, Liver, pancreatic, lung and Gastric
cancers. This treatment is called "Autologous Immune Enhancement
therapy" (AIET).
Successful used Dendritic cell therapy vaccines -
FDA Approved DENVAX for treating Liver Cancer, NON HOdgkin's
lymphoma, HODGKIN'S LYMPHOMA, Ovarian cancer, Mastoid Cancer,
Multiple Myeloma, Bone cancer, Lung cancer, Stomach cancer, Breast
cancer, Gallbladder cancer, Brain Cancer, CANCER CBD (involving
gallbladder/pancreas/chest wall), Prostate cancer
DENVAX
CUSTOMIZED DENDRITIC CELL IMMUNOTHERAPY IN CANCER
Denvax delays cancer progression and improves survival
DENVAX is Dendritic cell-based cancer immunotherapy.
Dendritic cells (DC) therapy delays cancer progression and
improves patient survival. At ICT, we have treated a number patients
with M1 (Metastatic) disease who are leading a recurrence-free
quality life for many months to years. We have the experience in
treating more than four hundred cancer patients, mostly solid tumors
in various stages of the disease.
DENVAX helps to prevent relapse
DENVAX shows most promise at preventing a recurrence of cancer
after surgery, chemotherapy or radiation because the immune system
will need to recognize and attack a smaller number of cancer cells.
DENVAX can be given in combination with other modalities of cancer
treatment. DENVAX can be given alone or in combination with the
other treatment modalities. Dendritic cell therapy comes under the
heading of Biological Therapy of Cancer, the fourth modality of
cancer treatment after surgery, radiation and chemotherapy.
Negligible adverse effects or toxicity as compared to chemotherapy.
DENVAX is customized treatment. It is designed to be safe and has
minimal side effects. Some patients may experience fever for a day
or two after taking DENVAX therapy. The components of DENVAX include
patient's own mononuclear cells manipulated into cancer-fighting
Dendritic cells; there is no graft versus host reaction, or acute-or
delayed-type hypersensitivity.
Ease of DENVAX manufacturing and administration
To manufacture DENVAX, patient's own mononuclear cells are
collected either by drawing a fresh sample of peripheral blood or by
aphaeresis procedure. The CD14+ cells are isolated and further
processed for 8 days to transform them into cancer-specific DC.
These Dendritic cells are then re-infused into the same patient on
the 8th day of drawing blood.
------------------------------------------------------------------------------------------------
Adult Stem Cell Issues
The only problem with adult stem cells is that these cells are
usually not found at high enough concentrations in the areas where
they are needed. If we consider people who have had a heart attack
or stroke, they contain much higher concentrations of stem cells in
their peripheral blood than healthy people. The reason for this is
because the body enlists stem cells to migrate to the injured
tissue in order to heal it. The problem is that in many cases there
are not enough stem cells available to promote full healing. Thus,
if one could increase the number of stem cells in the body then
theoretically, one could enhance the ability of the body to heal
itself. And indeed, this appears to be possible, as numerous studies
have shown that augmenting the body’s natural process through
administration of adult stem cells is highly beneficial to patients.
Examples of studies yielding positive data after adult stem cell
administration include heart failure, peripheral artery disease and
Crohn’s Disease.
------------------------------------------------------------------------------------------------
What is a clinical trial?
A clinical trial is a scientific study of potential new
treatments or medications for a particular disease or condition. It
is used to evaluate possible treatments that have potential effects
against the disease/condition. Scientists may test whether a
treatment is simply effective and safe, or if one treatment is more
effective than another. Of course, how well a drug is tolerated is
also a focus. A clinical trial involving human subjects is part of
the long and careful process in the evaluation of a treatment
candidate. If a new treatment or medication is proven effective AND
safe, it may become approved for use in a specific population.
What is the benefit for clinical trial
participants?
By participating in a clinical trial, a person helps
to provide valuable information about his or her disease and
possible treatment options. Participants may find the research to be
beneficial to themselves, though this is not always the case. A
trial may use a placebo (an inactive substance that helps determine
a potential treatment’s safety and effectiveness when compared to an
active drug or treatment) for some of those involved, or the therapy
in question might work for only certain participants and not others.
There is also a chance that a patient might experience an adverse
event or side effect from the use of the drug
What are stem cells?
Stem cells are unspecialized cells that have two important
characteristics that distinguish them from other cells in the body.
First, they can replenish their numbers for long periods through
cell division. Second, after receiving certain chemical signals,
they can differentiate, or transform into specialized cells with
specific functions, such as a heart cell or nerve cell.
Stem cells can be classified by the extent to which they can
differentiate into different cell types:
- Totipotent stem cells can differentiate into any
cell type in the body plus the placenta, which nourishes the embryo.
A fertilized egg is a type of totipotent stem cell. Cells produced
in the first few divisions of the fertilized egg are also
totipotent.
- Pluripotent stem cells are descendants of the
totipotent stem cells of the embryo. These cells, which develop
about four days after fertilization, can differentiate into any cell
type, except for totipotent stem cells and the cells of the
placenta.
- Multipotent stem cells are descendents of
pluripotent stem cells and antecedents of specialized cells in
particular tissues. For example, hematopoietic stem cells, which are
found primarily in the bone marrow, give rise to all of the cells
found in the blood, including red blood cells, white blood cells,
and platelets. Another example is neural stem cells, which can
differentiate into nerve cells and neural support cells called glia.
- Progenitor cells (or unipotent stem cells) can
produce only one cell type. For example, erythroid progenitor cells
differentiate into only red blood cells.
At the end of the long chain of cell divisions are "terminally
differentiated" cells, such as a liver cell or lung cell, which are
permanently committed to specific functions. These cells stay
committed to their functions for the life of the organism or until a
tumor develops. In the case of a tumor, the cells dedifferentiate,
or return to a less mature state.
Research is now being conducted on both adult and embryonic stem
cells to determine the characteristics and potential of both to cure
disease.
Over 40,000 stem cells transplants are performed worldwide each year,
providing recovery from ones-fatal diseases. Experts believe that
such transplants will be the answer for many of today's incurable
diseases.
Stem cells are primitive immature cells which have the ability to
self-replicate and differentiate into any formed blood elements:
white cells., red cells and platelets. This allows them to act as a
repair system for the body, replenishing other cells as long as the
organism is alive.
Blood stem cells can be collected from the bone marrow or bloodstream
of:
++ Compatible family member or an unrelated donor.
++ An identical twin
++ Patient's own cells previously collected and suitably stored
What are the sources
of stem cells?
There are three sources of stem cells:
- Embryonic stem cells (ESCs) are derived from 4- to
5-day-old embryos. At this stage, the embryos are spherical and are
known as blastocysts. Each blastocyst consists of 50 to 150 cells
and includes three structures: an outer layer of cells, a
fluid-filled cavity, and a group of about 30 pluripotent cells at
one end of the cavity. This latter group of cells, called the inner
cell mass, form all the cells of the body.
ESC cultures are created in the laboratory by transferring the inner
cell mass from a blastocyst into a specially treated plastic culture
dish. The cells divide and, after several days, begin to crowd the
culture dish. When this happens, the cells are removed and plated
into several fresh culture dishes. This process is repeated many
times, eventually yielding millions of ESCs. If, after six months,
the cells keep dividing without differentiating, are still
pluripotent, and are genetically normal, they are referred to as an
ESC line.
The blastocysts used for creating ESC lines are derived from eggs that
were fertilized in in vitro fertilization clinics but never
implanted in a woman’s uterus. The resulting embryos were frozen and
later donated for research purposes with the informed consent of the
donors. Currently, there are over 400,000 unused frozen embryos in
U.S. fertility clinics.
Because ESCs are pluripotent and relatively easy to grow in cell
culture, they are attractive candidates for use in stem cell
therapies. However, just injecting ESCs into a site of injury would
probably result in a tumor growing in that spot. ESCs must first be
directed to differentiate into the desired cells, such as heart
muscle cells, blood cells, or nerve cells. To control ESC
differentiation in cell cultures, scientists try different
techniques, such as changing the chemical composition of the culture
medium, altering the surface of the culture dish, or inserting
specific genes into the cells.
One possible drawback to using differentiated ESC lines in stem cell
therapies is that ESCs from one person might illicit an immune
response when placed into another person, because the proteins on
the ESC surfaces might be viewed as foreign by the recipient’s
immune system. However, this is far from certain. ESC derivatives
have been transplanted between species (for example, pigs to rats)
without being rejected, so the possibility exists that ESC
derivatives from one person might be safely transplanted into
another person. Studies investigating this have yet to be done.
- Adult stem cells are undifferentiated cells that
are found in small numbers in most adult tissues. However, they are
also found in children and can be extracted from umbilical cord
blood. A more accurate phrase is “somatic stem cells,” although this
phrase has yet to be generally adopted.
The primary roles of adult stem cells in the body are to maintain and
repair the tissues in which they are found. They are usually thought
of as multipotent cells, giving rise to a closely related family of
cells within the tissue. An example is hematopoietic stem cells,
which form all the various cells in the blood.
Recent evidence, however, indicates that some adult stem cell types
may be pluripotent, or at least able to differentiate into multiple
cell types. For example, hematopoietic stem cells can differentiate
into neurons, glia, skeletal muscle cells, heart muscle cells, and
liver cells. Whether they actually do this ordinarily within the
body is unknown.
Blood from the placenta and umbilical cord that are left over after
birth is a rich source of hematopoietic stem cells. These so-called
umbilical cord stem cells have been shown to be able to
differentiate into bone cells and neurons, as well as the cells
lining the inside of blood vessels.
A potential advantage of using adult stem cells from a patient is that
the patient’s own cells could be expanded in culture, treated to
differentiate into the desired cells, and then reintroduced into the
patient. The use of the patient’s own cells would eliminate any
possibility that they might be rejected by the immune system.
Disadvantages of using adult stem cells are that they are rare in
mature tissues and it is more difficult to expand their numbers in
cell culture, compared with ESCs
- Embryonic (or fetal) germ cells are pluripotent
stem cells derived from so-called primordial germ cells, which are
the cells that give rise to the gametes (sperm and eggs) in adults.
Scientists obtain primordial germ cells from the area in a 5- to
9-week-old embryo/fetus destined to become either the testicles or
the ovaries (the dividing line between embryo and fetus is the end
of the 8th week). Like ESCs, the primordial germ cells are
transferred into a specially treated plastic culture dish, where
they form germ cell colonies.
Less research has been performed using embryonic germ (EG) cells than
ESCs, mostly because the embryos used for deriving EG cells are
deliberately aborted, while the blastocysts used for deriving ESCs
are produced through in vitro fertilization in a fertility clinic.
EG cells are also difficult to maintain in cell culture because they
have a tendency to differentiate spontaneously.
------------------------------------------------------------------------------------------------
CURING THE ONES INCURABLE
Dramatic breakthroughs in the field of Haematology and stem cell
transplant offer new hope in treating conditions where conventional
therapies have proven to be ineffective. These include
life-threatening blood disorders such as multiple myeloma, chronic
lymphatic leukaemia and Thalassaemia Major, which cannot be cured
using conventional therapies such as chemotherapy and radiotherapy.
With allogeneic stem cell transplant (using stem cells from
compatible family member or an unrelated donor), cure rates for some
of these previously "incurable" disorders are as high as 90%.
Leukaemia, for example, makes up about 40% of paediatric cancers and
was ones extremely difficult to cure. Yet, with stem cell
transplant, some of South East Asia's leading hospitals enjoys an
80% cure rate for lymphoblatic leukaemia, comparable to leading
paediatric cancer centres in USA and Europe. stem cell
transplantation also allows for higher doses of chemotherapy then
usual resulting in higher success rates.
|
TYPES OF STEM CELL TRANSPLANTS
There are 3 basic types of stem cell transplants:
autologous, allogeneic and syngeneic. Where the stem cells come
from determines the type of transplant.
AUTOLOGOUS STEM CELL TRANSPLANT
Chiefly used to treat lymphomas and multiple myeloma,
this transplant uses stem cells from either your bone marrow or
circulating blood. Your stem cells are removed before treatment
through a process called harvesting, and then frozen. After you
have received high doses of chemotherapy, radiation, or both,
the stem cells are thawed and given back to you.
ALLOGENEIC STEM CELL TRANSPLANT
This type of transplant is commonly used to treat
leukemia and other bone marrow disorders. here, the stem cells
come from a donor whose tissue type best matches the patient.
This is usually a family member.
One advantage of allogeneic stem cell transplant is that the donor
stem cells produce their own immune cells, which may help
destroy any cancer cells that remain after high-dose treatment.
Another possible advantage is that the donor can often be
recalled if needed to donate more stem cells. Stem cells from
healthy donors are also free of cancer cells.
SYNGENEIC STEM CELL TRANSPLANT
A rare type of allogeneic transplant where the donor is an
identical twin.
------------------------------------------------------------------------------------------------
PROCEDURE FOR STEM CELL TRANSPLANT
Like any major medical procedure, stem cell transplants
have several associated risks. To ensure that a transplant is
the best available option for a patient, doctors in leading
Institutions where stem cell research is carried out follow a
strict evaluation process before approving any case.
The patient must first be reviewed for indications to see if his
medical condition needs a transplant.
After that, HLA (Human Leucocytes Antigen) tissue typing for the
patient and his siblings is carried out. If there is no sibling,
unrelated donors are tested for matches. Ones there is a matched
donor - sibling or unrelated - planning and discussion can
begin.
Besides intensive medical assessments, pre-transplant evaluation
for the patient and donor includes blood tests and other
investigations like X-Rays.
When the date is scheduled, the patient undergoes a conditioning
regimen which includes taking medication to cleanse the body
system.
Two days after completing the conditioning regimen, the stem
cells will be infused via the patient's central line much like a
blood transfusion. This infusion rarely causes any side effects.
After the infusion of stem cells, doctors will wait for the growth
of the new blood cells. It takes about two to three weeks before
the first white cells re-appear.
What follows is a recovery period nd intensive follow-up lasting
the first three months.
------------------------------------------------------------------------------------------------
Stem cell treatment for Spinal
Cord Injury
Our associated SC Induction Therapy Hospital have recently
developed a comprehensive program for SCI patients combining
both nerve stem cell activation and stimulation treatment and
self stem cells injections. This combined treatment has so far
proved itself to be most efficient in bringing high level of
recovery.
The treatment includes self stem cell implantation, a ‘cocktail’
of medications and brain nutrition materials given through IV,
biofeedback treatment and comprehensive rehabilitation.
By employing all of the above methods we can maximally improve
functions such as sensibility, mobility, also we can management
the pain and the improve the bowel and bladder control.
The key to the success of this treatment method is the overall
customized treatment regimen for each patient.
Self Stem Cells Activation and
Proliferation:
Under non-invasive circumstances, through daily IV of
individually customized cocktail of neurotrophic medicines we
activating the patient’s own stem cells and thus turning these
cells into nerve precursor cells. These have signalization
and migrate to lesions along the nerve developing-chord.
Self Stem Cells Injections:
1. Before injection of the stem cells, we will use
medicine to ablate the glial scars.
Glial scar in a chronic injury represents a physical and
molecular barrier to axonal regeneration. Before the injection
of stem cells, We will use medicine to ablate the scar and
create a benefit microenvironment for the stem cells to remove
to the injury cite, which is an important part to treat the
chronic spinal cord injury
2. Collection of self stem cells
First doctors will collect potential stem cell from bone marrow,
then they culture and proliferate them into Mesenchymal Stem
Cells (MSC). Usually this procedure need 3-4 weeks to get enough
amount of MSC (4,000,000). Then an experienced orthopedic
surgeon implants these Mesenchymal Stem Cells (MSC) either
through the CSF (spinal cord fluid) by a lumber puncture or
through a surgery under the instruction of Navigation equipment
into the damaged area, depending on the medical conditions of
the patient. Each injection had 1,000,000 stem cells. The big
advantage of this treatment is, there is no immune side effect
since those stem cells are from patient’s own body, therefore,
there is no need to use immunosuppressant drugs.
During the time of culturing cells, we will precede the self
stem cell activation program, traditional medicine and
Comprehensive Rehabilitation to the patients. The surgery itself
will be quit safe to be undertaken.
Rehabilitation :
Rehabilitation therapy is very much necessary as a part of the
entire treatment regimen.
The adult stem cell mobilization technique we use is combined
with signal induction in the rehabilitation training procedure
which can significantly improve brain function.
In our Rehabilitation center we use different kind of
rehabilitation methods such as: Physical Therapy, Occupational
Therapy, Speech Therapy and Traditional Medicine.
Treatment period:
The recommended period of time for treatment is 8 weeks .
Signing up for treatment:
If a SCI patient is considering having this treatment you will
need to send us medical information about the patient’s
condition including all original X-ray's and or MRI's
radiological films. A consultation fee of US$ 100/- is charged
to evaluate medical records of SCI patients. Our medical team
will have a thorough consultation about the case, and we will
then come back to you with their evaluation and suggested course
of action. The more information you will provide our doctors
could give you a more accurate evaluation and estimation of the
chances for improvements and recovery from the treatment.
You have two options of sending
medical records:
1. If you can have the digital images you may send them as
attachments along with your diagnosis and medical background via
email: < arun.kumar@mediescapes.com>
Send us your medical records here once consultation fees are
paid by swift wire bank transfer.
2. You can send us your medical records by air mail / courier
mail to our mailing address. Make sure to use express mail so
you can track the package if necessary.
Please send the package to the following address:
To: Mediescapes India,
No. 24, Peepal Apts., Sector 17, Pocket E,
Dwarka Phase II, New Delhi - 110 075 (India)
Please mention Cell phone No.: 981162 4141 after address
line
Our international department team will be happy to answer any of
your question.
If you made the decision of coming for treatment please ask us
to send you patient questionnaire form for SCI treatment and get
the questionnaire form filled by your doctor and attach it with
rest of the medical records to send the same to us.
Signing up for treatment is easy and flexible – we need to know
your date of arrival two weeks in advanced so we can reserve you
a room and arrange to pick you up from the airport. You need to
meet the Invoice treatment payment before arrival via swift wire
bank transfer.
Our international department team will help you to figure out
all the arrangement for your trip. For more information about
traveling arrangements ask us once you give consent to treatment
plan suggested to you.
------------------------------------------------------------------------------------------------
Current status of Stem Cell Research /
Activity in India
Manipal Hospital, Bangalore
(South India)
Activities: Cardiac, Neurosurgery, Vascular Surgery,
Diabetes, Ophthalmology, Cancers (Has country’s first clean
room)
Sir Gangaram Hospital, Delhi (North
India)
Activities: To be advised
L.V. Prasad Eye
Institute, Hyderabad
Activities: Ophthalmology (Clean Room Planned)
MIOT Hospitals, Chennai (South India)
Activities:: Neurosurgery
AIIMS, Delhi (North India)
Activities:: Cardiac, Neurosurgery, Vascular Surgery,
Diabetes, Ophthalmology, Cancers (10 departments involved)
Narayana Hrudyalaya, Bangalore (South
India)
Activities:: Cardiac
Asian Heart Foundation, Mumbai (West
India)
Activities:: Cardiac
Christian Medical
College, Vellore (South India)
Activities:: Cardiac, Diabetes (Clean Room planned)
Sri Ramchandra Medical College,
Chennai (South India)
Activities:: Various (Claims to treat 75 diseases)
Center for Cellular and Molecular Biology,
Hyderabad (South India)
Activities:: Ophthalmology
Army Research and Referral Hospital, Delhi (North India)
Activities:: To be advised
Frontier Lifeline
Hospital, Chennai (South India)
Activities: Cardiac
Sanjay Gandhi Post
Graduate Institute for Medical Sciences, Lucknow (North
India)
Activities:: Cardiac (Clean Room planned)
Air Force Medical
College, Pune (West India)
Activities: Cardiac
Post Graduate Institute
of Medical Education & Research, Chandigarh (North India)
Activities: Cardiac (Clean Room Planned)
KEM Hospital,
Mumbai
Activities:: To be advised (Clean Room Planned)
Shankar Nethralaya,
Chennai (South India)
Activities:: Ophthalmology
Dr. Agarwal’s Hospital, Chennai
(South India)
Activities: Ophthalmology
Ruby Hall Medical Research Center,
Pune (West India)
Activities: To be advised
Maulana Azad Medical College, Delhi
(north India)
Activities: Unknown
Jaslok Hospital, Mumbai (West India)
Activities: To be advised
Deccan Medical College, Hyderabad
(South India)
Activities: Liver
Inlaks and Budharani Hospital,
Pune (West India)
Activities:: To be advised
Public Cord Blood /
Stem Cell Banks And Research Centres in India
Reliance Life Sciences,
Mumbai (West India)
Activities: Stem Cell Lines for skin, ophthalmology and
going forward, cardiac and neuro disorders
Life Cell – in collaboration with
Cryo Cell (USA), Chennai (South India)
Activities:: Unknown
StemOne Biologicals Pvt. Ltd
– Started in 2005 with cord blood banking, Pune (West India)
Activities:: Started in 2008 Stem Cell therapy
Jawaharlal Nehru Centre for Advanced
Scientific Research, Bangalore (South India)
Activities:: Pure Research
National Centre For Cell Sciences,
Pune (West India)
Activities: Only Research
Indian Institute of
Sciences, Bangalore (South India)
Activities: Only Research
National Centre for
Biological Science, Bangalore (South India)
Activities: Only Research
Notes:
India’s first cord blood transplant took place in a beta
Thalassemia case at Tata Memorial Hospital in late 90’s followed
by Army Research and Referral Hospital, Delhi. It was also the
first one to establish a BMT unit in 1983.
First ever Cord Blood banking facility was
started in New York’s Milstien National Cord Blood Centre.
Reliance Life Sciences, Mumbai was the first in India to
establish a Cord Blood Repository.
The Department of Biotechnology under the
Ministry of Science and Technology and Indian Council of Medical
Research have jointly formulated draft guidelines for stem cell
research. The guidelines are currently being placed for public
debate. As per the guidelines, stem cell research has been
classified under permissible, restricted and prohibited
categories. The research pertaining to adult and umbilical cord
blood stem cells would be classified as permissible. It would
require approval from institutional committee. However,
embryonic stem cell research falls under restricted category. It
can be carried out with the approval of institutional committees
and National Apex Committee. Research pertaining to reproductive
cloning and introducing animal embryos in humans has been
categorized as prohibited.
For Detailed Dossier on Stem Cell research, please write to us at
mktg@mediescapes.com
|